Strategic Contract2026-05-21
Hanmi Pharm secures 10-year cardiovascular/respiratory drug supply contract
HAN
한미사이언스
008930
Signal Score
59C — Neutral
Score59 / 100
Historical Avg Return (5d)
+1.26%
Data Coverage
100%n=599
Risk-adjusted indicator based on 599 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Value: 52.74B KRW
- • % of Recent Revenue: 3.4%
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 단일판매ㆍ공급계약체결(자회사의 주요경영사항) . Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.